A Hidden Shunt Behind Post-COVID-19 Dyspnea: Partial Anomalous Pulmonary Venous Connection.

Publication date: Apr 01, 2026

Persistent exertional dyspnea following SARS-CoV-2 infection is frequently attributed to post-viral pulmonary pathology. When symptoms are accompanied by right ventricular (RV) dilation and pulmonary hypertension without elevated left-sided filling pressures, alternative etiologies including congenital heart disease must be considered. A 52-year-old man with prior COVID-19 pneumonia presented with one year of progressive exertional dyspnea. Transthoracic echocardiography demonstrated preserved left ventricular systolic function with RV dilation. Right heart catheterization revealed mild precapillary pulmonary hypertension with a significant oxygen saturation step-up at the superior vena cava-right atrial level. Cardiac computed tomography angiography confirmed partial anomalous pulmonary venous connection (PAPVC) with a sinus venosus atrial septal defect. This case emphasizes the necessity of maintaining a broad differential in patients with persistent dyspnea following COVID-19, cautioning against anchoring bias toward post-viral sequelae. While initial suspicion focused on Group 3 pulmonary hypertension, the findings of RV dilation and a normal pulmonary capillary wedge pressure mandated further investigation. This suggests that the acute pulmonary insult may have physiologically unmasked a previously compensated, hemodynamically significant PAPVC. Ultimately, the integration of invasive hemodynamics, specifically identifying an oxygen saturation step-up, and multimodality imaging is essential to identify rare but correctable congenital anomalies in adults presenting with non-specific respiratory complaints.

Open Access PDF

Concepts Keywords
Hemodynamics covid 19
Hypertension oxygen saturation step-up
Old right heart catheterization
Pneumonia
Viral

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Dyspnea
pathway REACTOME SARS-CoV-2 Infection
disease MESH pulmonary hypertension
disease MESH congenital heart disease
drug DRUGBANK Oxygen
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH pneumonia
disease MESH heart failure
disease MESH chest pain
disease MESH syncope
disease MESH paroxysmal nocturnal dyspnea
disease MESH included
disease MESH essential hypertension
disease MESH viral pneumonia
disease MESH pulmonary disease
disease MESH idiopathic pulmonary arterial hypertension
disease MESH edema

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *